-
89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
Verhoeff, S. R., Oosting, S. F., Elias, S. G., van Es, S. C., Gerritse, S. L., Angus, L., Heskamp, S., Desar, I. M. E., Menke-van der Houven van Oordt, C. W., van der Veldt, A. A. M., Arens, A. I. J., Brouwers, A. H., Eisses, B., Mulders, P. F. A., Hoekstra, O. S., Zwezerijnen, G. J. C., van der Graaf, W. T. A., Aarntzen, E. H. J. G., Oyen, W. J. G. & van Herpen, C. M. L., 1 Feb 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 3, p. 592-601 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors
Gerritse, S. L., Labots, M., Heine, R. T., Dekker, H., Poel, D., Tauriello, D. V. F., Nagtegaal, I. D., van den Hombergh, E., van Erp, N. & Verheul, H. M. W., 1 Dec 2022, In: Cancers. 14, 24, 6061.Research output: Contribution to journal › Article › Academic › peer-review
-
High-dose administration of tyrosine kinase inhibitors to improve clinical benefit: A systematic review
Gerritse, S. L., Janssen, J. B. E., Labots, M., de Vries, R., Rudek, M., Carducci, M., van Erp, N. P. & Verheul, H. M. W., Jun 2021, In: Cancer Treatment Reviews. 97, 102171.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications